Security key
87164U508
Theriva Biologics, Inc. - Common stock (TOVX)
CUSIP: 87164U508
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common stock
- Shares outstanding
- 9,600,143
- Total 13F shares
- 1,295,504
- Share change
- +858,452
- Total reported value
- $272,379
- Price per share
- $0.21
- Number of holders
- 20
- Value change
- +$158,821
- Number of buys
- 14
- Number of sells
- 10
Report period
Q4 2025
Institutions
20
Top holders
10
TOVX full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Theriva Biologics, Inc. SEC filings
Theriva Biologics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87164U508
Recent filing periods:
Top shareholders of TOVX - Theriva Biologics, Inc. - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Jeffrey Matthew Gryga Irrevocable Trust |
13D/G
|
— |
7.7%
|
739,211
|
$300,046 | $0 | 24 Oct 2025 | |
| Empery Asset Management, LP |
13D/G
|
— |
5%
|
504,091
|
$201,636 | -$179,638 | 30 Sep 2025 | |
| CVI Investments, Inc. |
13D/G
|
— |
4.9%
|
146,136
|
$206,052 | $0 | 31 Dec 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.3%
|
120,031
|
$48,625 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.64%
|
61,837
|
$25,050 | — | 30 Sep 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.38%
|
36,781
|
$15,000 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.38%
|
36,771
|
$14,896 | — | 30 Sep 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.37%
|
35,601
|
$14,422 | — | 30 Sep 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.34%
|
32,899
|
$13,327 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.29%
|
28,209
|
$11,427 | — | 30 Sep 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.28%
|
27,284
|
$11,053 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.24%
|
22,913
|
$9,280 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.17%
|
16,382
|
$6,635 | — | 30 Sep 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.11%
|
10,142
|
$4,000 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.08%
|
7,506
|
$3,041 | — | 30 Sep 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
444
|
$172 | — | 30 Sep 2025 | |
| Clear Street Group Inc. |
13F
|
Company |
0%
|
100
|
$41 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
80
|
$32 | — | 30 Sep 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
59
|
$24 | — | 30 Sep 2025 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
11
|
$4 | — | 30 Sep 2025 | |
| Wealthspire Advisors, LLC |
13F
|
Company |
0%
|
2
|
$1 | — | 30 Sep 2025 | |
| Francis Tufaro |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
100,000
|
— | — | 15 Dec 2022 |
Institutional Holders of Theriva Biologics, Inc. - Common stock (TOVX) as of Q4 2025
As of 31 Dec 2025,
Theriva Biologics, Inc. - Common stock (TOVX) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,295,504 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, UBS Group AG, Ikarian Capital, LLC, TWO SIGMA SECURITIES, LLC, TWO SIGMA INVESTMENTS, LP, DRW Securities, LLC, XTX Topco Ltd, and StoneX Group Inc..
This page lists
20
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
18
Q4 2025 holders
20
Holder diff
2
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.